Skip to main content
. 2018 Nov 29;9:2753. doi: 10.3389/fimmu.2018.02753

Table 1.

Histopathological findings in MOG antibody-associated disorders. Modified after (12, 24).

Sex Age Clinical diagnosis Neuropathological classification Inflammatory infiltrates and confluent demyelinationa Perivascular complement deposition and/or AQP-4 lossb Eosinophilic cell infiltrationb Comment References
M 71 Fulminant encephalomyelitis MS pattern II, in addition lesions with complement activation and AQP4 loss + + in a single lesion of optic chiasm nr Late seroconversion to low-titer AQP-4 antibody positivity during disease course (91)
M 46 Encephalitis, ADEM-like lesions and unilateral optic neuritis Mild inflammatory changes na na na No demyelinating lesions (56)
F 29 Cerebral cortical encephalitis with epilepsy and bilateral optic neuritis Inflammatory infiltrates in the cortex and subcortex na na na No demyelinating lesions (58)
F 63 CIS MS pattern II + (93)
W 49 RRMS MS pattern II + (90)
M 49 ADEM MS pattern II with an overlap of MS pattern III + Oligodendrocyte apoptosis and loss (94)
M 34 ADEM MS pattern II +
F 66 Recurrent myelitis and brainstem involvement followed by tumefactive bilateral lesions MS pattern II + (92)
F 67 NMOSD, recurrent myelitis followed by cerebral tumefactive lesions No pattern classification, inflammatory demyelination without astrocyte loss + nr nr (47)
a

Typical neuropathological findings of MS and NMOSD.

b

Typical neuropathological findings of NMOSD, nr, not reported; na, not applicable.